These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14765332)

  • 41. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
    Lonn EM; Yusuf S
    Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.
    Briançon S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S
    Int J Epidemiol; 2011 Dec; 40(6):1605-16. PubMed ID: 22158670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Primary cardiovascular prevention with aspirin].
    Seguí Díaz M; Escobar C; Divisón JA
    Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antioxidant therapy in vascular and renal diseases].
    Tepel M; van der Giet M; Zidek W
    Med Klin (Munich); 2002 Mar; 97(3):144-51. PubMed ID: 11957789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ramipril can do more. Halting progression of atherosclerosis].
    MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530
    [No Abstract]   [Full Text] [Related]  

  • 47. [Drug therapy in the secondary prevention of atherosclerosis].
    Kettunen R
    Duodecim; 2002; 118(20):2093-101. PubMed ID: 12463000
    [No Abstract]   [Full Text] [Related]  

  • 48. [Functional foods or nutritional-dose supplementations: what does the future hold for micronutrition in ophtalmology?].
    Desmettre T; Lecerf JM
    J Fr Ophtalmol; 2005 Mar; 28(3):239-42. PubMed ID: 15883487
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.
    Verdecchia P; Sleight P; Mancia G; Fagard R; Trimarco B; Schmieder RE; Kim JH; Jennings G; Jansky P; Chen JH; Liu L; Gao P; Probstfield J; Teo K; Yusuf S;
    Circulation; 2009 Oct; 120(14):1380-9. PubMed ID: 19770395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiovascular protection and prevention in patients with cardiac conditions and diabetes].
    Charpentier G; Puel J; Steg PG
    Presse Med; 2005 Oct; 34(18):1295-8. PubMed ID: 16269992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of 6-month multivitamin supplementation on serum concentrations of alpha-tocopherol, beta-carotene, and vitamin C in healthy elderly women.
    Wolters M; Hermann S; Hahn A
    Int J Vitam Nutr Res; 2004 Mar; 74(2):161-8. PubMed ID: 15255454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients?
    Evans MF
    Can Fam Physician; 1998 Dec; 44():2655-7. PubMed ID: 9870118
    [No Abstract]   [Full Text] [Related]  

  • 53. Antioxidant vitamins and cardiovascular disease: current knowledge and future directions.
    Hennekens CH
    Nutrition; 1998 Jan; 14(1):50-1. PubMed ID: 9437682
    [No Abstract]   [Full Text] [Related]  

  • 54. More hype than HOPE.
    Moutsatsos GD
    Hypertension; 2003 Apr; 41(4):e4; author reply e5. PubMed ID: 12623866
    [No Abstract]   [Full Text] [Related]  

  • 55. [Can arteriosclerosis be prevented by antioxidants?].
    Møgelvang B
    Nord Med; 1992; 107(2):53-6. PubMed ID: 1538962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
    Masson C
    Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
    [No Abstract]   [Full Text] [Related]  

  • 57. A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.
    González-Juanatey JR; Mostaza JM; Lobos JM; Abarca B; Llisterri JL
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):547-50. PubMed ID: 27062678
    [No Abstract]   [Full Text] [Related]  

  • 58. [Atherosclerosis. High ACE activity in plaque: risk of rupture!].
    MMW Fortschr Med; 2001 Oct; 143(43):51. PubMed ID: 11715882
    [No Abstract]   [Full Text] [Related]  

  • 59. Antioxidants and atherosclerosis: don't throw out the baby with the bath water.
    Jialal I; Devaraj S
    Circulation; 2003 Feb; 107(7):926-8. PubMed ID: 12600900
    [No Abstract]   [Full Text] [Related]  

  • 60. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.